NegativeReview/Other2013
The pathophysiology and pharmacological treatment of Huntington disease
Classification Results
AI Classification
NegativeFine-tuned Classification
N/AAI Classification
NegativeFine-tuned Classification
N/ACorrection: Computational approach for the evaluation of sesquiterpene lactone as a modulator of cannabinoid receptor type 2 for neurodegenerative disease prophylactics
USO DE CANNABIDIOL (CBD) EM DOENÇAS NEURODEGENERATIVAS E OUTRAS CONDIÇÕES NEUROLÓGICAS: ATUALIZAÇÕES EM EVIDÊNCIAS CLÍNICAS E PERSPECTIVAS TERAPÊUTICAS
Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1G93 A) mouse model of amyotrophic lateral sclerosis
Utilizing ADMET Analysis and Molecular Docking to Elucidate the Neuroprotective Mechanisms of a Cannabis-Containing Herbal Remedy (Suk-Saiyasna) in Inhibiting Acetylcholinesterase
Ginsenoside RK1 inhibits microglial activation and ROS production and alleviates vascular dementia in rats
Cognitive Effects of Cannabis Use Across the Lifespan: A Review for Clinical Practice